# Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity

> **NCT02143934** · PHASE4 · COMPLETED · sponsor: **Papua New Guinea Institute of Medical Research** · enrollment: 524 (actual)

## Conditions studied

- Plasmodium Vivax Infection
- Plasmodium Vivax Clinical Episode
- Plasmodium Falciparum Infection
- Plasmodium Falciparum Clinical Episode

## Interventions

- **DRUG:** Primaquine
- **DRUG:** Placebo
- **DRUG:** Chloroquine
- **DRUG:** Artemether Lumefantrine

## Key facts

- **NCT ID:** NCT02143934
- **Lead sponsor:** Papua New Guinea Institute of Medical Research
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-05
- **Final completion:** 2014-05
- **Target enrollment:** 524 (ACTUAL)
- **Last updated:** 2014-05-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02143934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02143934, "Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02143934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*